Effectiveness of Corticosteroid and 5% Dextrose Versus USG-guided Ozone Injections in Patients With Carpal Tunnel Syndrome: Three Blind Randomized Studies
Yunus Burak Bayır
72 participants
Jan 1, 2025
INTERVENTIONAL
Conditions
Summary
Effectiveness of corticosteroid and 5% dextrose versus USG-guided ozone injections in patients with carpal tunnel syndrome: Three blind randomized studies
Eligibility
Inclusion Criteria5
- Being between 18-65 years old
- Have been clinically diagnosed with carpal tunnel syndrome
- Confirmation of moderate CTS diagnosis with EMG
- Having typical CTS symptoms for at least 3 months
- Not having benefited from splinting and rest
Exclusion Criteria4
- History of polyneuropathy, brachial plexopathy, thoracic outlet syndrome or wrist surgery
- History of inflammatory arthritis, hypothyroidism, pregnancy, rheumatologic disorders or pacemaker
- Current warfarin use, previous corticosteroid injection for CTS, trauma or neoplasm at the injection site, hypersensitivity to corticosteroids or skin infection(injection site)
- G6PD deficiency, hyperthyroidism, thrombocytopenia, severe cardiovascular instability and those receiving ACE inhibitors
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Each patient will receive 2 ml 10 μg/ml ozon perineural injection into the median nerve under US guidance, for 1 session.
Each patient will receive 2 ml:(1 ml betamethasone dipropionate+1ml saline) perineural injection into the median nerve under US guidance, for 1 session.
Each patient will receive 2 ml %5 dextrose perineural injection into the median nerve under US guidance, for 1 session.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07002892